253 related articles for article (PubMed ID: 34093538)
1. The Expression of Chemokines Is Downregulated in a Pre-Clinical Model of TTR V30M Amyloidosis.
Moreira J; Costelha S; Saraiva M; Saraiva MJ
Front Immunol; 2021; 12():650269. PubMed ID: 34093538
[TBL] [Abstract][Full Text] [Related]
2. TLR2 and 4 signaling pathways are altered in macrophages from V30M TTR mice with down-regulated expression of chemokines.
Moreira J; Martins H; Saraiva M; Saraiva MJ
Clin Sci (Lond); 2023 Mar; 137(5):355-366. PubMed ID: 36852978
[TBL] [Abstract][Full Text] [Related]
3. The inflammatory response to sciatic nerve injury in a familial amyloidotic polyneuropathy mouse model.
Gonçalves NP; Teixeira-Coelho M; Saraiva MJ
Exp Neurol; 2014 Jul; 257():76-87. PubMed ID: 24800914
[TBL] [Abstract][Full Text] [Related]
4. A low amyloidogenic E61K transthyretin mutation may cause familial amyloid polyneuropathy.
Murakami T; Yokoyama T; Mizuguchi M; Toné S; Takaku S; Sango K; Nishimura H; Watabe K; Sunada Y
J Neurochem; 2021 Mar; 156(6):957-966. PubMed ID: 32852783
[TBL] [Abstract][Full Text] [Related]
5. Effect of albumin on transthyretin and amyloidogenic transthyretin Val30Met disposition and tissue deposition in familial amyloidotic polyneuropathy.
Taguchi K; Jono H; Kugimiya-Taguchi T; Nagao S; Su Y; Yamasaki K; Mizuguchi M; Maruyama T; Ando Y; Otagiri M
Life Sci; 2013 Dec; 93(25-26):1017-22. PubMed ID: 24211615
[TBL] [Abstract][Full Text] [Related]
6. MMP-14 overexpression correlates with the neurodegenerative process in familial amyloidotic polyneuropathy.
Martins D; Moreira J; Gonçalves NP; Saraiva MJ
Dis Model Mech; 2017 Oct; 10(10):1253-1260. PubMed ID: 28993312
[TBL] [Abstract][Full Text] [Related]
7. Modeling familial amyloidotic polyneuropathy (Transthyretin V30M) in Drosophila melanogaster.
Berg I; Thor S; Hammarström P
Neurodegener Dis; 2009; 6(3):127-38. PubMed ID: 19372706
[TBL] [Abstract][Full Text] [Related]
8. Human transthyretin gene expression is markedly increased in repair Schwann cells in an in vitro model of hereditary transthyretin amyloidosis.
Murakami T; Ito Y; Sango K; Watabe K; Sunada Y
Neurochem Int; 2023 Mar; 164():105507. PubMed ID: 36796540
[TBL] [Abstract][Full Text] [Related]
9. Schwann cells contribute to neurodegeneration in transthyretin amyloidosis.
Murakami T; Sango K; Watabe K; Niimi N; Takaku S; Li Z; Yamamura K; Sunada Y
J Neurochem; 2015 Jul; 134(1):66-74. PubMed ID: 25693163
[TBL] [Abstract][Full Text] [Related]
10. Decreased expression of S100A8/A9 in V30M related ATTRv amyloidosis.
Moreira J; Martins S; Saraiva M; Saraiva MJ
Amyloid; 2023 Sep; 30(3):327-334. PubMed ID: 36947059
[TBL] [Abstract][Full Text] [Related]
11. The transthyretin gene is expressed in Schwann cells of peripheral nerves.
Murakami T; Ohsawa Y; Zhenghua L; Yamamura K; Sunada Y
Brain Res; 2010 Aug; 1348():222-5. PubMed ID: 20547140
[TBL] [Abstract][Full Text] [Related]
12. Presence of N-glycosylated transthyretin in plasma of V30M carriers in familial amyloidotic polyneuropathy: an escape from ERAD.
Teixeira AC; Saraiva MJ
J Cell Mol Med; 2013 Mar; 17(3):429-35. PubMed ID: 23387326
[TBL] [Abstract][Full Text] [Related]
13. Hereditary transthyretin amyloidosis: a model of medical progress for a fatal disease.
Adams D; Koike H; Slama M; Coelho T
Nat Rev Neurol; 2019 Jul; 15(7):387-404. PubMed ID: 31209302
[TBL] [Abstract][Full Text] [Related]
14. Neurodegeneration in familial amyloid polyneuropathy: from pathology to molecular signaling.
Sousa MM; Saraiva MJ
Prog Neurobiol; 2003 Dec; 71(5):385-400. PubMed ID: 14757117
[TBL] [Abstract][Full Text] [Related]
15. Glial cells in familial amyloidotic polyneuropathy.
Gonçalves NP; Costelha S; Saraiva MJ
Acta Neuropathol Commun; 2014 Dec; 2():177. PubMed ID: 25519307
[TBL] [Abstract][Full Text] [Related]
16. Protective role of anakinra against transthyretin-mediated axonal loss and cell death in a mouse model of familial amyloidotic polyneuropathy.
Gonçalves NP; Teixeira-Coelho M; Saraiva MJ
J Neuropathol Exp Neurol; 2015 Mar; 74(3):203-17. PubMed ID: 25668561
[TBL] [Abstract][Full Text] [Related]
17. Familial amyloidotic polyneuropathy: protein aggregation in the peripheral nervous system.
João Saraiva M; Mendes Sousa M; Cardoso I; Fernandes R
J Mol Neurosci; 2004; 23(1-2):35-40. PubMed ID: 15126690
[TBL] [Abstract][Full Text] [Related]
18. Deposition of transthyretin amyloid is not accelerated by the same amyloid in vivo.
Wei L; Kawano H; Fu X; Cui D; Ito S; Yamamura K; Ishihara T; Tokuda T; Higuchi K; Maeda S
Amyloid; 2004 Jun; 11(2):113-20. PubMed ID: 15478467
[TBL] [Abstract][Full Text] [Related]
19. Fibroblasts endocytose and degrade transthyretin aggregates in transthyretin-related amyloidosis.
Misumi Y; Ando Y; Gonçalves NP; Saraiva MJ
Lab Invest; 2013 Aug; 93(8):911-20. PubMed ID: 23817086
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-1 signaling pathway as a therapeutic target in transthyretin amyloidosis.
Gonçalves NP; Vieira P; Saraiva MJ
Amyloid; 2014 Sep; 21(3):175-84. PubMed ID: 24918964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
